Ategrity Specialty Insurance Company Holdings, through its subsidiaries, provides excess and surplus lines insurance and reinsurance products to small and medium-sized businesses in the United States. The company offers property and casualty insurance solutions, including general liability, commercial property, management liability, miscellaneous PL, allied healthcare, and architects and engineers insurance products to the retail, real estate, hospitality, and construction sectors. It markets and distributes its products through brokerage and small business channels. The company was formerly known as Ategrity Specialty Holdings LLC and changed its name to Ategrity Specialty Insurance Company Holdings in June 2025. Ategrity Specialty Insurance Company Holdings was incorporated in 2017 and is based in New York, New York. Ategrity Specialty Insurance Company Holdings operates as a subsidiary of Zimmer Financial Services Group LLC.…
Ategrity Specialty Insurance Company Holdings (ASIC) Could Be 20% Below Fair Value On Q3 Results
Ategrity Specialty Insurance Company Holdings (NYSE: ASIC) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Property & Casualty industry, part of the Financial Services sector, and reports about 203 employees.
The shares were at 24.77 USD on 20 November 2026, up 35.5% over 52 weeks. Its 52-week range is 16.73 USD to 28.96 USD: the price is 14.5% below the high and 48.1% above the low.
At a market capitalisation of 1.18B USD, it trades at 13.0 times trailing earnings and 10.0 times forward earnings. The median trailing P/E of its 19 largest Insurance - Property & Casualty peers is 12.9, so ASIC is valued in line with them.
Ategrity Specialty Insurance Company Holdings reports return on equity of 12.0%, an operating margin of 24.5% and revenue up 8.2% year over year.
It holds more cash than debt, a net cash position of 219.54M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 28.40 USD is 14.7% above the current price. The next earnings report is expected on 18 February 2027.